drugset / Trial / NCT02127073

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

NCT02127073 ↗

Phase 2 Terminated 8 enrolled Montefiore Medical Center
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to examine the genetic material called microRNA of three types of specimens from women with breast cancer. The study also seeks to examine the effectiveness of using a new agent called oxytocin to increase the amount of nipple fluid that can be collected during surgery.

Timeline

Start
2015-01-30
Primary completion
2017-01-18
Completion
2017-09-18

Outcome

Outcome not reported

Stopped (Business): “Could not identify collaborator and secure additional funding after transferring the record to Montefiore Medical Center”

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 4 iu Intranasal